SCIENTIFIC AND MEDICAL EQUIPMENT HOUSE COMPANY

Balance Sheet Scientific and Medical Equipment House Company

Stocks

4014

SA15GGQ1UN19

Healthcare Facilities & Services

Delayed Saudi Arabian S.E. Other stock markets 13:20:00 15/07/2026 BST			5-day change	1st Jan Change
28.50 ^SAR	-1.32%		-2.66%	-10.15%

07-06	Scientific & Medical Equipment House Wins SAR95 Million Deal with Saudi Arabia's Justice Ministry	MT
07-06	Scientific & Medical Equipment House Co. Announces The Award Of A Project With The Ministry Of Justice Valued At SAR 95,000,059.05	CI

91ad947ceac89f0e5dfd74e4d3546ad0.HxpeJJTrMBy_kpW7J8cz9eq7x-d0a19AemeBh28XUJ4.K1AUEM2EAlTx_PSNYoVlgYLqirIyIwcuFivKyhhtHMl-WGlop7tkd9Cr9g

Published financial data: SCIENTIFIC AND MEDICAL EQUIPMENT HOUSE COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	699M	714M	799M	877M	877M
Total Revenues	699M	714M	799M	877M	877M
Cost of Goods Sold, Total	547M	560M	667M	744M	755M
Gross Profit	153M	154M	133M	133M	122M
Selling General & Admin Expenses, Total	70.36M	78.18M	87.89M	82.9M	80.85M
Provision for Bad Debts	-	39.43M	-21.51M	-4.57M	4.32M
Other Operating Expenses, Total	70.36M	118M	66.38M	78.33M	85.17M
Operating Income	82.39M	36.17M	66.13M	54.83M	36.39M
Interest Expense, Total	-12.95M	-19.65M	-25.29M	-25.32M	-15.12M
Interest And Investment Income	330K	51.4K	-	-	-
Net Interest Expenses	-12.62M	-19.6M	-25.29M	-25.32M	-15.12M
Other Non Operating Income (Expenses)	14.84M	11.08M	12.09M	16.3M	18.07M
EBT, Excl. Unusual Items	84.62M	27.65M	52.93M	45.8M	39.34M
Gain (Loss) On Sale Of Assets	218K	89.08K	20.55K	88.14K	826K
Insurance Settlements	-	-	-	-	-
EBT, Incl. Unusual Items	84.83M	27.74M	52.95M	45.89M	40.17M
Income Tax Expense	8.09M	12.12M	15.15M	14.65M	13.95M
Earnings From Continuing Operations	76.75M	15.62M	37.8M	31.23M	26.21M
Earnings Of Discontinued Operations	-	-	-	-6.63M	-
Net Income to Company	76.75M	15.62M	37.8M	24.61M	26.21M
Minority Interest	775K	1.95M	2.26M	1.56M	2.23M
Net Income - (IS)	77.52M	17.57M	40.06M	26.17M	28.44M
Net Income to Common Incl Extra Items	77.52M	17.57M	40.06M	26.17M	28.44M
Net Income to Common Excl. Extra Items	77.52M	17.57M	40.06M	32.79M	28.44M
Per Share Items
Net EPS - Basic	2.58	0.59	1.34	0.87	0.95
Basic EPS - Continuing Operations	2.58	0.59	1.34	1.09	0.95
Basic Weighted Average Shares Outstanding	30M	30M	30M	30M	30M
Net EPS - Diluted	2.58	0.59	1.34	0.87	0.95
Diluted EPS - Continuing Operations	2.58	0.59	1.34	1.09	0.95
Diluted Weighted Average Shares Outstanding	30M	30M	30M	30M	30M
Normalized Basic EPS	1.79	0.64	1.18	1.01	0.89
Normalized Diluted EPS	1.79	0.64	1.18	1.01	0.89
Dividend Per Share	0.67	-	1	1	-
Payout Ratio	38.7	113.85	-	114.64	105.49
Supplemental Items
EBITDA	91.47M	47.73M	79.11M	64.9M	46.08M
EBITA	82.39M	37M	66.86M	54.98M	36.57M
EBIT	82.39M	36.17M	66.13M	54.83M	36.39M
EBITDAR	98.76M	56.75M	85.36M	70.19M	53.64M
Effective Tax Rate - (Ratio)	9.53	43.7	28.61	31.93	34.74
Normalized Net Income	53.66M	19.23M	35.34M	30.19M	26.81M
Interest on Long-Term Debt	264K	624K	1.5M	975K	1.08M
Non-Cash Pension Expense	1.03M	1.34M	2.53M	2.71M	3.45M
Supplemental Operating Expense Items
Advertising Expense	220K	275K	141K	25.66K	1.85M
Selling and Marketing Expenses	9.91M	9.48M	17.38M	21.18M	25.16M
General and Administrative Expenses	57.52M	65M	65.87M	56.84M	49.73M
Net Rental Expense, Total	7.29M	9.03M	6.25M	5.3M	7.56M
Imputed Operating Lease Interest Expense	3.3M	6M	4.44M	3.76M	4.58M
Imputed Operating Lease Depreciation	3.99M	3.02M	1.81M	1.54M	2.98M
Maintenance & Repair Expenses, Total	234K	1.07M	543K	431K	546K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	45.32M	54.56M	16.95M	88.06M	20.47M
Total Cash And Short Term Investments	45.32M	54.56M	16.95M	88.06M	20.47M
Accounts Receivable, Total	712M	611M	805M	610M	708M
Other Receivables	4.7M	6.72M	12.53M	6.99M	5.16M
Total Receivables	717M	618M	818M	617M	713M
Inventory	97.24M	97.68M	105M	103M	65.85M
Prepaid Expenses	38.57M	37.85M	38.03M	27.48M	25.97M
Other Current Assets, Total	43.73M	30.23M	24.38M	34.58M	29.32M
Total Current Assets	942M	838M	1B	870M	855M
Gross Property Plant And Equipment	107M	136M	157M	151M	149M
Accumulated Depreciation	-62.93M	-79.2M	-95.42M	-104M	-108M
Net Property Plant And Equipment	43.82M	57.24M	62.07M	46.24M	41.24M
Long-term Investments	-	-	-	-	-
Other Intangibles, Total	-	3.69M	2.5M	971K	1.24M
Other Long-Term Assets, Total	32.33M	31.92M	37.34M	34.34M	36.35M
Total Assets	1.02B	931M	1.1B	952M	933M
Liabilities
Accounts Payable, Total	65.11M	68.49M	49.73M	56.25M	47.99M
Accrued Expenses, Total	124M	94.76M	67.75M	61.21M	60.32M
Short-term Borrowings	248M	178M	332M	185M	170M
Current Portion of Long-Term Debt	500K	164K	1.25M	1.55M	1.75M
Current Portion of Leases	4.74M	8.23M	9.47M	5.68M	6.98M
Current Income Taxes Payable	6.93M	12.16M	15.46M	15.01M	16.59M
Unearned Revenue Current, Total	5.61M	3.79M	23.93M	27.08M	38.31M
Other Current Liabilities	19.04M	13.03M	9.5M	8.99M	7.68M
Total Current Liabilities	474M	379M	509M	361M	350M
Long-Term Debt	7.22M	9.67M	8.32M	6.78M	5.02M
Long-Term Leases	5.77M	10.61M	11.52M	9.01M	7.52M
Pension & Other Post Retirement Benefits	56.8M	63.61M	68.08M	70.08M	70.16M
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	544M	462M	597M	447M	433M
Common Stock, Total	200M	200M	300M	300M	300M
Retained Earnings	273M	270M	211M	211M	209M
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	473M	470M	511M	511M	509M
Minority Interest	218K	-1.74M	-4M	-5.62M	-7.84M
Total Equity	474M	469M	507M	505M	501M
Total Liabilities And Equity	1.02B	931M	1.1B	952M	933M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	30M	30M	30M	30M	30M
ECS Total Common Shares Outstanding	30M	30M	30M	30M	30M
Book Value / Share	15.78	15.68	17.03	17.02	16.96
Tangible Book Value	473M	467M	508M	510M	507M
Tangible Book Value Per Share	15.78	15.56	16.94	16.99	16.91
Total Debt	266M	207M	363M	208M	192M
Net Debt	221M	152M	346M	120M	171M
Debt Equivalent of Unfunded Proj. Benefit Obligation	56.8M	63.61M	68.08M	70.08M	70.16M
Debt Equivalent Oper. Leases	58.28M	72.21M	50.02M	42.39M	60.47M
Minority Interest, Total (Incl. Fin. Div)	218K	-1.74M	-4M	-5.62M	-7.84M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	94.53M	100M	109M	104M	67.18M
Inventories - Others	12.53M	11.13M	12.77M	13.14M	13.64M
Buildings, Total	676K	676K	588K	588K	622K
Machinery, Total	76.35M	87.59M	98.2M	98.7M	98.84M
Full Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	9.24M	48.66M	27.95M	23.36M	24.91M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	77.52M	17.57M	40.06M	26.17M	28.44M
Depreciation & Amortization - CF	13.16M	17.02M	21.91M	19.21M	17.54M
Amortization of Goodwill and Intangible Assets - (CF)	-	833K	737K	151K	180K
Depreciation & Amortization, Total	13.16M	17.85M	22.64M	19.36M	17.72M
(Gain) Loss From Sale Of Asset	-218K	-89.08K	-20.55K	413K	-826K
Provision and Write-off of Bad Debts	4.47M	39.43M	21.51M	-4.57M	4.32M
Net Cash From Discontinued Operations	-	-	-	-6.26M	-
Other Operating Activities, Total	16.29M	14.19M	34.15M	39.08M	16.63M
Change In Accounts Receivable	-222M	75.15M	-226M	216M	-101M
Change In Inventories	-12.15M	-4.58M	-10.37M	3.18M	34.93M
Change In Accounts Payable	6.88M	8.34M	-18.76M	6.52M	-8.26M
Change in Unearned Revenues	-1.36M	-1.82M	2.43M	4.02M	4.1M
Change in Other Net Operating Assets	45.52M	-42.02M	-6.75M	-17.97M	12.96M
Cash from Operations	-72.04M	124M	-141M	286M	8.75M
Capital Expenditure	-7.45M	-13.29M	-14.88M	-4.43M	-7.08M
Sale of Property, Plant, and Equipment	240K	166K	1.08M	2.29M	2.58M
Divestitures	-	-	-	-3.17M	-
Sale (Purchase) of Real Estate properties	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-4.53M	456K	-	-453K
Investment in Marketable and Equity Securities, Total	11.67M	-	-	-	-
Other Investing Activities, Total	201K	70.52K	-1.59M	2.66M	-2.36M
Cash from Investing	4.67M	-17.58M	-14.93M	-2.65M	-7.31M
Short Term Debt Issued, Total	798M	1.01B	1.07B	764M	560M
Long-Term Debt Issued, Total	5.86M	2.11M	-	-	-
Total Debt Issued	804M	1.01B	1.07B	764M	560M
Short Term Debt Repaid, Total	-733M	-1.08B	-916M	-911M	-575M
Long-Term Debt Repaid, Total	-3.67M	-9.19M	-13.39M	-10.53M	-9.68M
Total Debt Repaid	-736M	-1.09B	-930M	-922M	-584M
Issuance of Common Stock	-	-	-	-	-
Common Dividends Paid	-30M	-20M	-	-30M	-30M
Common & Preferred Stock Dividends Paid	-30M	-20M	-	-30M	-30M
Other Financing Activities, Total	-13.64M	-	-23.05M	-24.35M	-14.43M
Cash from Financing	24.06M	-97.2M	118M	-212M	-69.02M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-43.32M	9.24M	-37.61M	71.12M	-67.59M
Supplemental Items
Cash Interest Paid	12.68M	-	23.05M	24.35M	14.43M
Levered Free Cash Flow	-129M	94.23M	-197M	239M	-26.11M
Unlevered Free Cash Flow	-121M	107M	-182M	254M	-16.66M
Change In Net Working Capital	178M	-83.87M	231M	-205M	49.59M
Net Debt Issued / Repaid	67.7M	-77.2M	141M	-158M	-24.59M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.4	2.32	4.06	3.33	2.41
Return on Total Capital	7.57	3.2	5.35	4.33	3.24
Return On Equity %	16.99	3.31	7.75	6.17	5.21
Return on Common Equity	17.2	3.72	8.17	6.42	5.58
Margin Analysis
Gross Profit Margin %	21.84	21.54	16.58	15.18	13.87
SG&A Margin	10.06	10.95	11	9.45	9.22
EBITDA Margin %	13.08	6.69	9.9	7.4	5.26
EBITA Margin %	11.78	5.18	8.37	6.27	4.17
EBIT Margin %	11.78	5.07	8.27	6.25	4.15
Income From Continuing Operations Margin %	10.97	2.19	4.73	3.56	2.99
Net Income Margin %	11.08	2.46	5.01	2.98	3.24
Net Avail. For Common Margin %	11.08	2.46	5.01	3.74	3.24
Normalized Net Income Margin	7.67	2.69	4.42	3.44	3.06
Levered Free Cash Flow Margin	-18.41	13.2	-24.7	27.2	-2.98
Unlevered Free Cash Flow Margin	-17.25	14.92	-22.72	29	-1.9
Asset Turnover
Asset Turnover	0.73	0.73	0.79	0.85	0.93
Fixed Assets Turnover	16.22	14.13	13.4	16.2	20.04
Receivables Turnover (Average Receivables)	1.12	1.08	1.13	1.24	1.33
Inventory Turnover (Average Inventory)	5.96	5.75	6.58	7.15	8.93
Short Term Liquidity
Current Ratio	1.99	2.21	1.97	2.41	2.44
Quick Ratio	1.61	1.78	1.64	1.95	2.1
Operating Cash Flow to Current Liabilities	-0.15	0.33	-0.28	0.79	0.02
Days Sales Outstanding (Average Receivables)	327.05	338.31	322.04	296.29	274.3
Days Outstanding Inventory (Average Inventory)	61.27	63.52	55.48	51.22	40.86
Average Days Payable Outstanding	39.3	43.5	32	26.13	26.5
Cash Conversion Cycle (Average Days)	349.02	358.33	345.52	321.38	288.65
Long Term Solvency
Total Debt/Equity	56.21	44.08	71.6	41.22	38.24
Total Debt / Total Capital	35.98	30.59	41.72	29.19	27.66
LT Debt/Equity	2.74	4.33	3.92	3.13	2.51
Long-Term Debt / Total Capital	1.76	3	2.28	2.21	1.81
Total Liabilities / Total Assets	53.46	49.67	54.1	46.94	46.34
EBIT / Interest Expense	6.36	1.84	2.61	2.17	2.41
EBITDA / Interest Expense	7.38	2.75	3.51	2.93	3.58
(EBITDA - Capex) / Interest Expense	6.8	2.07	2.92	2.75	3.11
Total Debt / EBITDA	2.79	3.82	4.09	2.81	3.54
Net Debt / EBITDA	2.31	2.81	3.9	1.62	3.16
Total Debt / (EBITDA - Capex)	3.02	5.07	4.91	2.98	4.07
Net Debt / (EBITDA - Capex)	2.51	3.73	4.68	1.72	3.64
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13.28	2.05	11.97	12.95	-0.06
Gross Profit, 1 Yr. Growth %	1.53	0.67	-13.83	3.43	-8.71
EBITDA, 1 Yr. Growth %	-1.79	-47.82	65.75	-24.43	-29.38
EBITA, 1 Yr. Growth %	-5.11	-55.09	80.69	-26.41	-33.48
EBIT, 1 Yr. Growth %	-5.11	-56.1	82.82	-26.47	-33.63
Earnings From Cont. Operations, 1 Yr. Growth %	3.49	-79.65	142.07	-33.58	-16.07
Net Income, 1 Yr. Growth %	3.7	-77.34	128.04	-34.68	8.68
Normalized Net Income, 1 Yr. Growth %	4.35	-64.16	83.75	-26.56	-10.94
Diluted EPS Before Extra, 1 Yr. Growth %	3.7	-77.34	128.04	-33.46	-13.28
Accounts Receivable, 1 Yr. Growth %	31.54	-14.18	33.04	-24.74	16.05
Inventory, 1 Yr. Growth %	12.66	0.45	7.53	-1.74	-36.2
Net Property, Plant and Equip., 1 Yr. Growth %	3.32	30.65	8.42	-25.5	-10.82
Total Assets, 1 Yr. Growth %	14.44	-8.53	18.58	-13.79	-1.93
Tangible Book Value, 1 Yr. Growth %	10.62	-1.43	8.91	0.27	-0.43
Common Equity, 1 Yr. Growth %	10.62	-0.65	8.59	-0.03	-0.38
Cash From Operations, 1 Yr. Growth %	-161.41	-272.15	-195.83	-303.21	-96.94
Capital Expenditures, 1 Yr. Growth %	-67.58	78.38	11.99	-70.25	59.92
Levered Free Cash Flow, 1 Yr. Growth %	-355.04	-173.19	-301.55	-223.26	-110.93
Unlevered Free Cash Flow, 1 Yr. Growth %	-306.87	-188.28	-264.76	-242.93	-106.54
Dividend Per Share, 1 Yr. Growth %	-33.33	-	-	0	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8.24	7.52	6.9	10.86	6.25
Gross Profit, 2 Yr. CAGR %	7.01	1.1	-6.86	-6.95	-2.83
EBITDA, 2 Yr. CAGR %	14.07	-28.42	-7	16.61	-26.75
EBITA, 2 Yr. CAGR %	11.42	-34.72	-9.91	21.89	-30.04
EBIT, 2 Yr. CAGR %	11.42	-35.46	-10.41	23.12	-30.14
Earnings From Cont. Operations, 2 Yr. CAGR %	4.41	-54.11	-29.82	41.43	-25.34
Net Income, 2 Yr. CAGR %	4.74	-51.53	-28.12	22.05	-15.74
Normalized Net Income, 2 Yr. CAGR %	9.84	-38.85	-18.85	25.28	-19.23
Diluted EPS Before Extra, 2 Yr. CAGR %	4.74	-51.53	-28.12	36.63	-24.03
Accounts Receivable, 2 Yr. CAGR %	8.18	6.25	6.34	0.39	-6.55
Inventory, 2 Yr. CAGR %	83.45	6.38	3.93	2.79	-20.82
Net Property, Plant and Equip., 2 Yr. CAGR %	33.88	16.18	19.02	-10.12	-18.49
Total Assets, 2 Yr. CAGR %	8.67	2.31	4.15	1.11	-8.05
Tangible Book Value, 2 Yr. CAGR %	15.42	4.42	3.61	4.5	-0.08
Common Equity, 2 Yr. CAGR %	15.34	4.83	3.87	4.19	-0.2
Cash From Operations, 2 Yr. CAGR %	-33.49	2.82	39.72	39.55	-75.06
Capital Expenditures, 2 Yr. CAGR %	-15.92	-23.95	41.34	-42.28	-31.03
Levered Free Cash Flow, 2 Yr. CAGR %	22.28	36.62	23.83	56.08	-63.27
Unlevered Free Cash Flow, 2 Yr. CAGR %	10.81	35.13	22.68	51.93	-69.41
Dividend Per Share, 2 Yr. CAGR %	-	-	22.47	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.2	6.14	8.98	7.84	7.09
Gross Profit, 3 Yr. CAGR %	5.22	4.85	-4.14	-4.47	-7.54
EBITDA, 3 Yr. CAGR %	2.08	-12.11	-5.3	-10.81	-1.16
EBITA, 3 Yr. CAGR %	0.52	-17.7	-8.34	-12.61	-0.39
EBIT, 3 Yr. CAGR %	0.52	-18.32	-8.68	-12.69	0.2
Earnings From Cont. Operations, 3 Yr. CAGR %	3.96	-39.47	-20.12	-25.89	18.85
Net Income, 3 Yr. CAGR %	4.43	-37.12	-18.78	-30.37	17.42
Normalized Net Income, 3 Yr. CAGR %	4.79	-24.38	-11.75	-17.45	11.71
Diluted EPS Before Extra, 3 Yr. CAGR %	4.43	-37.12	-18.78	-24.93	17.42
Accounts Receivable, 3 Yr. CAGR %	6.93	0.15	14.15	-5.03	5.36
Inventory, 3 Yr. CAGR %	57.91	50.08	6.76	2.01	-12.32
Net Property, Plant and Equip., 3 Yr. CAGR %	57.98	32.8	13.54	1.81	-10.36
Total Assets, 3 Yr. CAGR %	6.38	2.61	7.47	-2.21	0.08
Tangible Book Value, 3 Yr. CAGR %	16.42	9.5	5.9	2.48	2.83
Common Equity, 3 Yr. CAGR %	16.34	9.74	6.07	2.55	2.64
Cash From Operations, 3 Yr. CAGR %	-12.78	-8.68	6.23	58.3	-60.94
Capital Expenditures, 3 Yr. CAGR %	35.93	8.04	-13.48	-15.93	-18.93
Levered Free Cash Flow, 3 Yr. CAGR %	-3.84	3.05	57.55	22.83	-35.64
Unlevered Free Cash Flow, 3 Yr. CAGR %	-3.37	2.72	46.02	28.23	-46.73
Dividend Per Share, 3 Yr. CAGR %	-	-	0	14.47	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	5.11	6.48	8	7.26
Gross Profit, 5 Yr. CAGR %	-	7.21	0.21	-0.04	-4.17
EBITDA, 5 Yr. CAGR %	-	-4.68	-1.66	-1.59	-13.13
EBITA, 5 Yr. CAGR %	-	-7.52	-3.79	-3.7	-15.88
EBIT, 5 Yr. CAGR %	-	-7.94	-4	-3.75	-15.96
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-20.67	-11.16	-15	-18.78
Net Income, 5 Yr. CAGR %	-	-18.69	-10.06	-18.02	-17.58
Normalized Net Income, 5 Yr. CAGR %	-	-12.03	-5.4	-7.46	-12.21
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-18.69	-10.06	-14.23	-17.58
Accounts Receivable, 5 Yr. CAGR %	-	7.34	6.69	0.05	5.51
Inventory, 5 Yr. CAGR %	-	14.87	33.58	29	-5.27
Net Property, Plant and Equip., 5 Yr. CAGR %	-	35.24	41.06	13.6	-0.56
Total Assets, 5 Yr. CAGR %	-	7.21	5.48	2.01	0.97
Tangible Book Value, 5 Yr. CAGR %	-	13.01	11.12	7.47	3.46
Common Equity, 5 Yr. CAGR %	-	13.11	11.18	7.49	3.51
Cash From Operations, 5 Yr. CAGR %	-	9.74	5.31	11.91	-40.5
Capital Expenditures, 5 Yr. CAGR %	-	33.02	38.06	-15.92	-20.98
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	6.39	22.61	-12.35
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	6.31	20.96	-22.17